Drug intelligence / Profile preview

Nattokinase Plus

Development stage
Unknown
Lead developer
DaVinci Laboratories
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Nattokinase Plus is an oral dietary supplement product developed and marketed by DaVinci Laboratories for cardiovascular and circulation support. It is a combination nutraceutical containing nattokinase as the principal fibrinolytic enzyme, together with serratiopeptidase and rutin. The product is positioned to support healthy blood flow, fibrin turnover, capillary integrity, and vascular health rather than as an FDA-approved therapeutic for a specific disease. Mechanistically, nattokinase is generally described as a proteolytic enzyme with fibrinolytic activity that may promote breakdown of fibrin and support endogenous thrombolytic balance, while serratiopeptidase is a proteolytic enzyme often marketed for complementary protease activity and rutin is a flavonoid antioxidant used to support capillary strength and vascular function.

Brand names
Nattokinase Plus
02

Targets

F7 (Coagulation Factor VII)HS (Heparan sulfate)PLG (Plasminogen)PAI-1 (Plasminogen activator inhibitor type 1)F8 (Coagulation Factor VIIIa)Fibrin (Factor Ia)

Beyond the preview

Go deeper on Nattokinase Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nattokinase Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call